Cambridge Investment Research Advisors’s Barings Corporate Investors MCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.25M Buy
128,057
+10,543
+9% +$185K 0.01% 1592
2026
Q1
$2.03M Buy
117,514
+30,080
+34% +$599K 0.01% 1579
2025
Q4
$1.59M Buy
87,434
+649
+0.7% +$13.2K ﹤0.01% 1731
2025
Q3
$1.8M Buy
86,785
+2,050
+2% +$43.5K ﹤0.01% 1582
2025
Q2
$1.83M Sell
84,735
-139
-0.2% -$2.85K 0.01% 1491
2025
Q1
$1.99M Buy
84,874
+4,895
+6% +$103K 0.01% 1352
2024
Q4
$1.63M Sell
79,979
-69
-0.1% -$1.36K 0.01% 1507
2024
Q3
$1.59M Buy
80,048
+17,932
+29% +$332K 0.01% 1528
2024
Q2
$1.16M Buy
62,116
+11,156
+22% +$199K ﹤0.01% 1658
2024
Q1
$876K Buy
50,960
+17,883
+54% +$326K ﹤0.01% 1816
2023
Q4
$610K Buy
33,077
+12,390
+60% +$206K ﹤0.01% 2033
2023
Q3
$330K Buy
20,687
+2,569
+14% +$39.4K ﹤0.01% 2426
2023
Q2
$270K Sell
18,118
-408
-2% -$5.76K ﹤0.01% 2627
2023
Q1
$262K Sell
18,526
-495
-3% -$7.01K ﹤0.01% 2600
2022
Q4
$266K Sell
19,021
-13,577
-42% -$183K ﹤0.01% 2526
2022
Q3
$422K Sell
32,598
-16,910
-34% -$235K ﹤0.01% 2071
2022
Q2
$664K Sell
49,508
-2,963
-6% -$42.2K ﹤0.01% 1744
2022
Q1
$799K Buy
52,471
+248
+0.5% +$3.86K ﹤0.01% 1738
2021
Q4
$835K Buy
52,223
+16,624
+47% +$265K ﹤0.01% 1709
2021
Q3
$554K Buy
35,599
+1,300
+4% +$20K ﹤0.01% 1964
2021
Q2
$521K Buy
34,299
+6,514
+23% +$96.6K ﹤0.01% 2024
2021
Q1
$387K Buy
27,785
+8,941
+47% +$121K ﹤0.01% 2090
2020
Q4
$248K Buy
18,844
+129
+0.7% +$1.64K ﹤0.01% 2297
2020
Q3
$234K Sell
18,715
-2,163
-10% -$28.6K ﹤0.01% 2124
2020
Q2
$281K Sell
20,878
-1,699
-8% -$22.6K ﹤0.01% 1936
2020
Q1
$262K Sell
22,577
-5,324
-19% -$82.4K ﹤0.01% 1756
2019
Q4
$471K Sell
27,901
-2,949
-10% -$49.4K ﹤0.01% 1623
2019
Q3
$520K Sell
30,850
-3,190
-9% -$51.8K ﹤0.01% 1470
2019
Q2
$533K Buy
34,040
+969
+3% +$15.2K ﹤0.01% 1381
2019
Q1
$511K Sell
33,071
-2,982
-8% -$46.4K ﹤0.01% 1466
2018
Q4
$530K Buy
36,053
+6,237
+21% +$94.1K 0.01% 1284
2018
Q3
$457K Sell
29,816
-1,665
-5% -$25.5K ﹤0.01% 1498
2018
Q2
$476K Sell
31,481
-1,205
-4% -$18.3K 0.01% 1423
2018
Q1
$494K Sell
32,686
-5,004
-13% -$75.4K 0.01% 1361
2017
Q4
$575K Buy
37,690
+337
+0.9% +$5.3K 0.01% 1244
2017
Q3
$590K Sell
37,353
-4,732
-11% -$74.1K 0.01% 1154
2017
Q2
$635K Sell
42,085
-96
-0.2% -$1.46K 0.01% 1055
2017
Q1
$644K Sell
42,181
-21,688
-34% -$329K 0.01% 947
2016
Q4
$989K Buy
63,869
+4,843
+8% +$79.9K 0.02% 682
2016
Q3
$1.01M Buy
59,026
+8,585
+17% +$157K 0.02% 675
2016
Q2
$906K Buy
50,441
+9,412
+23% +$164K 0.02% 650
2016
Q1
$698K Buy
41,029
+4,605
+13% +$77.7K 0.02% 727
2015
Q4
$628K Buy
36,424
+23,202
+175% +$394K 0.01% 758
2015
Q3
$215K Buy
13,222
+228
+2% +$3.68K 0.01% 1218
2015
Q2
$209K Buy
+12,994
New +$206K 0.01% 1270

Other funds holding MCI

Cambridge Investment Research Advisors's MCI Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Barings Corporate Investors (MCI) stake by 9% in Q2 2026, buying an estimated $185K and bringing the position to 128,057 shares worth $2.25M. The position accounts for 0.01% of the portfolio, ranked #1592.

Cambridge Investment Research Advisors first reported a position in MCI in Q2 2015 and has held it in 45 quarters since. 21 funds tracked by Wall St. Rank hold MCI as of Q2 2026.

  • Cambridge Investment Research Advisors held 128,057 shares of Barings Corporate Investors worth $2.25M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 10,543 Barings Corporate Investors shares in Q2 2026, an estimated $185K.
  • Barings Corporate Investors made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1592 holding.
  • Cambridge Investment Research Advisors first reported a position in Barings Corporate Investors in Q2 2015 and has held it in 45 quarters since.
  • 21 funds tracked by Wall St. Rank held Barings Corporate Investors as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.